Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway. (20th April 2017)
- Record Type:
- Journal Article
- Title:
- Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway. (20th April 2017)
- Main Title:
- Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway
- Authors:
- Gibault, Floriane
Bailly, Fabrice
Corvaisier, Matthieu
Coevoet, Mathilde
Huet, Guillemette
Melnyk, Patricia
Cotelle, Philippe - Abstract:
- Abstract: Porphyrin derivatives, in particular verteporfin (VP), a photosensitizer initially designed for cancer therapy, have been identified as inhibitors of the YAP–TEAD interaction and transcriptional activity. Herein we report the efficient convergent synthesis of the dipyrrin half of protoporphyrin IX dimethyl ester (PPIX‐DME), in which the sensitive vinyl group was created at the final stage by a dehydroiodination reaction. Two other dipyrrin derivatives were synthesized, including dipyrrin19 [( Z )‐2‐((3, 5‐dimethyl‐4‐vinyl‐2 H ‐pyrrol‐2‐ylidene)methyl)‐3, 5‐dimethyl‐4‐vinyl‐1 H ‐pyrrole], containing two vinyl groups. We found that VP and dipyrrin19 showed significant inhibitory effects on TEAD transcriptional activity in MDA‐MB‐231 human breast cancer cells, whereas other compounds did not show significant changes. In addition, we observed a marked decrease in both YAP and TAZ levels following VP treatment, whereas dipyrrin19 treatment primarily decreased the levels of YAP and receptor kinase AXL, a downstream target of YAP. Together, our data suggest that, due to their chemical structures, porphyrin‐ and dipyrrin‐related derivatives can directly target YAP and/or TAZ proteins and inhibit TEAD transcriptional activity. Abstract : Directed dipyrrins : An efficient convergent synthesis yielded hexasubstituted dipyrrins structurally related to verteporfin (VP), with a sensitive vinyl group created at the final stage by a dehydroiodination reaction. While VP showed aAbstract: Porphyrin derivatives, in particular verteporfin (VP), a photosensitizer initially designed for cancer therapy, have been identified as inhibitors of the YAP–TEAD interaction and transcriptional activity. Herein we report the efficient convergent synthesis of the dipyrrin half of protoporphyrin IX dimethyl ester (PPIX‐DME), in which the sensitive vinyl group was created at the final stage by a dehydroiodination reaction. Two other dipyrrin derivatives were synthesized, including dipyrrin19 [( Z )‐2‐((3, 5‐dimethyl‐4‐vinyl‐2 H ‐pyrrol‐2‐ylidene)methyl)‐3, 5‐dimethyl‐4‐vinyl‐1 H ‐pyrrole], containing two vinyl groups. We found that VP and dipyrrin19 showed significant inhibitory effects on TEAD transcriptional activity in MDA‐MB‐231 human breast cancer cells, whereas other compounds did not show significant changes. In addition, we observed a marked decrease in both YAP and TAZ levels following VP treatment, whereas dipyrrin19 treatment primarily decreased the levels of YAP and receptor kinase AXL, a downstream target of YAP. Together, our data suggest that, due to their chemical structures, porphyrin‐ and dipyrrin‐related derivatives can directly target YAP and/or TAZ proteins and inhibit TEAD transcriptional activity. Abstract : Directed dipyrrins : An efficient convergent synthesis yielded hexasubstituted dipyrrins structurally related to verteporfin (VP), with a sensitive vinyl group created at the final stage by a dehydroiodination reaction. While VP showed a direct effect on YAP and TAZ levels, one dipyrrin affected only YAP levels, suggesting that dipyrrin‐related compounds may directly affect the expression of YAP and/or TAZ. … (more)
- Is Part Of:
- ChemMedChem. Volume 12:Number 12(2017)
- Journal:
- ChemMedChem
- Issue:
- Volume 12:Number 12(2017)
- Issue Display:
- Volume 12, Issue 12 (2017)
- Year:
- 2017
- Volume:
- 12
- Issue:
- 12
- Issue Sort Value:
- 2017-0012-0012-0000
- Page Start:
- 954
- Page End:
- 961
- Publication Date:
- 2017-04-20
- Subjects:
- cancer -- dipyrrins -- Hippo pathway -- non-photoinduced therapy -- verteporfin
Pharmaceutical chemistry -- Periodicals
615.19005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/110485305 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cmdc.201700063 ↗
- Languages:
- English
- ISSNs:
- 1860-7179
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3172.254000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2797.xml